BPC-157 for Long COVID Brain Fog — Evidence Review Research from the University of Zagreb found that BPC-157 (body protection compound-157) modulates nitric oxide pathways in vascular endothelial tissue. The same pathwa…
Read articlePeptides for Stroke Recovery Research Compared — Real Peptides Cerebrolysin has been studied in 29 randomised controlled trials involving over 2,100 stroke patients. Yet the FDA has never approved it. That disconnect be…
Read articleBPC-157 Help TBI Research? Current Evidence & Limitations A 2019 study published in Brain Research Bulletin found that rats treated with BPC-157 within 30 minutes of controlled cortical impact showed 40% smaller lesion …
Read articleBest Research Peptides for Stroke Recovery Research Research conducted at Stanford's neuroscience division found that post-stroke neuroplasticity. The brain's capacity to rewire itself after ischemic damage. Peaks withi…
Read articleBPC-157 Studied TBI Research — What Science Shows Now A 2019 study published in the Journal of Physiology and Pharmacology found that rats administered BPC-157 immediately after controlled cortical impact showed 47% sma…
Read articleBPC-157 TBI Research Mechanism — Neural Repair Pathways A 2019 study from the University of Zagreb found that rats treated with BPC-157 after controlled cortical impact showed 60% reduction in lesion volume compared to …
Read articleBPC-157 for TBI Research — Neuroprotective Mechanisms Research conducted at the University of Zagreb found that BPC-157 administration within hours of experimentally induced TBI in rodents reduced lesion volume by 40% a…
Read articleBPC-157 Studied Concussion Recovery — Research Insights Research from the University of Zagreb published in 2014 demonstrated that BPC-157 (Body Protection Compound-157) reduced brain edema by 42% and improved motor coo…
Read articleDoes BPC-157 Help Concussion Recovery? (Research Update) A 2018 study published in the Journal of Physiology and Pharmacology found that BPC-157 reduced brain edema by 40% in rats subjected to traumatic brain injury com…
Read articleBPC-157 Concussion Recovery Mechanism — How It Works Research from Zagreb University's Department of Pharmacology found that BPC-157 administration within 30 minutes of traumatic brain injury reduced secondary glutamate…
Read articleBPC-157 for Concussion Recovery — Science Behind Healing Research published in the Journal of Physiology and Pharmacology in 2020 documented that BPC-157 administration within 24 hours of controlled cortical impact inju…
Read articlePeptides for Concussion Recovery Compared — Lab Insights Concussion recovery doesn't end when symptoms fade. A 2023 study published in Brain Injury found that 40% of patients still showed measurable white matter disrupt…
Read articleBest Research Peptides for Concussion Recovery — 2026 Nearly 3.8 million concussions occur annually in competitive and recreational sports. Yet fewer than 5% of athletes receive targeted peptide intervention during the …
Read articleMOTS-C Studied Mental Fatigue — Clinical Evidence Review Most discussions about mental fatigue focus on rest, caffeine, or nootropics. But those approaches miss the mechanism entirely. Research published in cellular met…
Read articleMOTS-c Mental Fatigue Mechanism — How It Shields the Brain Research from the University of Southern California published in 2015 identified MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) as the first peptid…
Read articleMOTS-C Help Mental Fatigue? (Mechanism & Evidence) A 2022 study from the University of Southern California found that MOTS-C administration improved exercise tolerance and metabolic flexibility in mice by 30–40% through…
Read articleThymosin Alpha-1 Studied Alopecia Areata — Research Review A 2003 pilot study published in the Journal of Dermatological Treatment followed 23 alopecia areata patients through 12 weeks of thymosin alpha-1 therapy. 39% s…
Read articleThymosin Alpha-1 Alopecia Areata Mechanism Explained A 2023 placebo-controlled trial published in the Journal of Dermatological Treatment found that 58% of alopecia areata patients treated with thymosin alpha-1 (Tα1) su…
Read articleDoes Thymosin Alpha-1 Help Alopecia Areata? Current Evidence A 1998 study published in the Journal of Dermatological Treatment found that 63% of patients with severe alopecia areata showed partial to complete hair regro…
Read articleThymosin Alpha-1 for Alopecia Areata — Immune Reset Data Most alopecia areata treatments target hair follicles directly. Minoxidil to stimulate growth, corticosteroids to suppress inflammation at the follicle site. Thym…
Read article